- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
- 长期趋势：
已有435家主力机构披露2024-06-30报告期持股数据，持仓量总计12.31亿股，占流通A股70.32%
- 波段诊断：
-
技术面诊股
诊断结果：6.6技术面打败了66%的股票
技术面评分前10的股票
近期的平均成本为37.87元。多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
平均成本
近期的平均成本为37.87元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"37.87","date":1733385378,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，接近行业平均水平。
[{"date":"2024.12.06","stock":"0.45","trade":"1.45","ind":"1.47"},{"date":"2024.12.05","stock":"1.02","trade":"0.59","ind":"0.29"},{"date":"2024.12.04","stock":"-2.26","trade":"-2.06","ind":"-1.02"},{"date":"2024.12.03","stock":"-2.09","trade":"-0.52","ind":"-0.40"},{"date":"2024.12.02","stock":"-0.41","trade":"2.71","ind":"1.36"},{"date":"2024.11.29","stock":"6.79","trade":"0.81","ind":"1.72"},{"date":"2024.11.28","stock":"0.55","trade":"0.42","ind":"-1.26"},{"date":"2024.11.27","stock":"3.80","trade":"1.64","ind":"2.25"},{"date":"2024.11.26","stock":"0.89","trade":"0.33","ind":"-0.84"},{"date":"2024.11.25","stock":"-1.28","trade":"1.42","ind":"-0.17"},{"date":"2024.11.22","stock":"-4.02","trade":"-4.61","ind":"-3.52"},{"date":"2024.11.21","stock":"0.49","trade":"0.33","ind":"-0.07"},{"date":"2024.11.20","stock":"3.23","trade":"3.02","ind":"0.78"},{"date":"2024.11.19","stock":"-0.03","trade":"1.85","ind":"1.90"},{"date":"2024.11.18","stock":"1.26","trade":"-2.26","ind":"-1.91"},{"date":"2024.11.15","stock":"-1.36","trade":"-2.02","ind":"-2.62"},{"date":"2024.11.14","stock":"-2.94","trade":"-2.97","ind":"-2.83"},{"date":"2024.11.13","stock":"0.08","trade":"-1.42","ind":"0.40"},{"date":"2024.11.12","stock":"2.22","trade":"0.85","ind":"-0.65"},{"date":"2024.11.11","stock":"-1.33","trade":"1.31","ind":"2.03"},{"date":"2024.11.08","stock":"0.00","trade":"-0.28","ind":"-0.66"}]
华东医药,深证成指,化学制药指数
压力支撑
该股压力位为37.63元，支撑位为37.17元。
[{"text":"\u538b\u529b\u4f4d","value":"37.63","date":1733414400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"37.17","date":1733414400,"color":"0x0b52a1"}]
多空趋势
多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.2资金面打败了24%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：12月06日 20:30
| 机构今日流向(万元) | 889.11 | 机构5日流向(万元) | -1547.64 |
| 机构10日流向(万元) | 1047.28 | 机构20日流向(万元) | -9911.80 |
机构持仓
2024-06-30 与 2023-12-31 相比，主力机构持仓量减少5082.85万股，其中基金净减仓10家，主力净减仓73家，请投资者中长期谨慎为宜。
截止2024-06-30，共435家主力机构（基金427家，券商集合理财2家，保险公司1家，一般法人4家，社保基金1家），持仓量总计123114.93万股，占流通A股70.32%
其中，基金持仓与2023-12-31相比：
增仓：124家 ，增持 2057.51万股
减仓：134家 ，减持 4130.63万股
新出现在主力名单中：132家 ，持有2151.3万股
从主力名单中消失：205家 ，原持有4444.24万股
其中，基金持仓与2023-12-31相比：
增仓：124家 ，增持 2057.51万股
减仓：134家 ，减持 4130.63万股
新出现在主力名单中：132家 ，持有2151.3万股
从主力名单中消失：205家 ，原持有4444.24万股
消息面诊股
诊断结果：5.9消息面打败了10%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 行业周报|化学制药指数涨2.12%, 跑输上证指数
2024-12-06 - 华东医药：公司肉毒素产品目前尚未在国内上市
2024-12-06 - ADC药物市场规模将增长至662亿美元，吸引大批创
2024-12-06 - ADC赛道竞争激烈 药企全力研发求突破
2024-12-06 - 华东医药：公司后续将根据项目情况选择海外临床开发路
2024-12-05 - 华东医药：公司自研产品的主要研究结果将视项目进展发
2024-12-05 - 华东医药大跌2.26%！工银瑞信基金旗下1只基金持
2024-12-05 - 华东医药：12月20日将召开2024年第二次临时股
2024-12-04 - 从来就没想过自体CAR-T能进医保
2024-12-04 - 国内首个！华东医药引进的ADC「索米妥昔单抗」获批
2024-12-04
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2024-12-05 |
| 一般消息 | 高管变动 | 因个人原因 | 2024-12-03 |
| 利好 | 分红转增 | 10派3.5元(含税) | 2024-08-16 |
| 一般消息 | 募资投向 | 公司购买资产 | 2024-07-22 |
| 一般消息 | 高管变动 | 因个人原因 | 2024-05-16 |
| 一般消息 | 重大事项 | 关联交易 | 2024-05-09 |
| 利好 | 分红转增 | 10派5.8元(含税) | 2024-04-18 |
| 一般消息 | 重大事项 | 关联交易 | 2024-04-18 |
| 一般消息 | 高管变动 | 审计委员会委员应当为不在上市公司担... | 2024-04-08 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-03-14 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-03-07 |
| 利好 | 业绩预告 | 业绩预增 | 2024-02-01 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-02-01 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：7.5行业面打败了82%的股票
化学制药行业最新资金流向
近10日来该行业走势明显向上，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势明显向上，跑赢大盘。
[{"date":"2024.12.06","price":"1.47","value":"1.45"},{"date":"2024.12.05","price":"0.29","value":"0.59"},{"date":"2024.12.04","price":"-1.02","value":"-2.06"},{"date":"2024.12.03","price":"-0.40","value":"-0.52"},{"date":"2024.12.02","price":"1.36","value":"2.71"},{"date":"2024.11.29","price":"1.72","value":"0.81"},{"date":"2024.11.28","price":"-1.26","value":"0.42"},{"date":"2024.11.27","price":"2.25","value":"1.64"},{"date":"2024.11.26","price":"-0.84","value":"0.33"},{"date":"2024.11.25","price":"-0.17","value":"1.42"},{"date":"2024.11.22","price":"-3.52","value":"-4.61"},{"date":"2024.11.21","price":"-0.07","value":"0.33"},{"date":"2024.11.20","price":"0.78","value":"3.02"},{"date":"2024.11.19","price":"1.90","value":"1.85"},{"date":"2024.11.18","price":"-1.91","value":"-2.26"},{"date":"2024.11.15","price":"-2.62","value":"-2.02"},{"date":"2024.11.14","price":"-2.83","value":"-2.97"},{"date":"2024.11.13","price":"0.40","value":"-1.42"},{"date":"2024.11.12","price":"-0.65","value":"0.85"},{"date":"2024.11.11","price":"2.03","value":"1.31"},{"date":"2024.11.08","price":"-0.66","value":"-0.28"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 前沿生物 | 25.23% | 15.83% | 5.0分 |
| 2 | 盟科药业 | 22.08% | 17.71% | 5.5分 |
| 3 | 一品红 | 19.47% | 7.74% | 6.5分 |
| 4 | 灵康药业 | 17.60% | 31.91% | 5.2分 |
| 5 | 贝达药业 | 17.44% | 3.92% | 6.8分 |
| 6 | 益方生物 | 16.67% | 28.30% | 5.5分 |
| 8 | 莱美药业 | 12.35% | 12.13% | 6.6分 |
| 10 | 德展健康 | 10.44% | 9.40% | 6.2分 |
| 12 | 康芝药业 | 9.12% | 11.15% | 5.9分 |
| 14 | 翰宇药业 | 8.87% | 7.87% | 6.8分 |
| 16 | 奥赛康 | 7.39% | -0.35% | 6.4分 |
| 18 | 人福医药 | 6.71% | 5.18% | 5.3分 |
| 20 | 广生堂 | 6.53% | 14.31% | 5.9分 |
| 22 | 亚太药业 | 6.52% | 5.92% | 6.7分 |
| 24 | 泽璟制药 | 6.08% | -2.01% | 5.2分 |
| 26 | 津药药业 | 5.67% | 1.30% | 5.3分 |
| 28 | 誉衡药业 | 5.07% | 14.62% | 6.6分 |
| 30 | 国邦医药 | 4.92% | -2.51% | 4.9分 |
| 32 | 键凯科技 | 4.81% | 8.38% | 5.2分 |
| 34 | 华东医药 | 4.61% | -3.28% | 6.2分 |
| 36 | 丰原药业 | 4.14% | 3.19% | 6.8分 |
| 38 | 永安药业 | 3.31% | -0.46% | 5.1分 |
| 40 | 汇宇制药 | 3.04% | 1.74% | 5.4分 |
| 42 | 迪哲医药 | 2.82% | -0.31% | 5.2分 |
| 44 | 信立泰 | 2.68% | -4.31% | 5.9分 |
| 46 | 宏源药业 | 2.50% | 0.80% | 5.2分 |
| 48 | 溢多利 | 2.07% | 2.60% | 5.4分 |
| 50 | 东亚药业 | 1.87% | 1.50% | 4.8分 |
| 52 | 汉商集团 | 1.73% | 1.98% | 5.4分 |
| 54 | 易明医药 | 1.67% | -0.77% | 4.7分 |
| 56 | 鲁抗医药 | 1.45% | 3.41% | 4.9分 |
| 58 | 天宇股份 | 1.40% | 0.40% | 6.2分 |
| 60 | 诚意药业 | 1.33% | 2.45% | 5.4分 |
| 62 | 力生制药 | 0.85% | 0.11% | 5.5分 |
| 64 | 同和药业 | 0.80% | 0.80% | 6.3分 |
| 66 | 辰欣药业 | 0.48% | 0.76% | 5.1分 |
| 68 | 福安药业 | 0.39% | 0.79% | 5.7分 |
| 70 | 恒瑞医药 | 0.06% | -2.29% | 5.6分 |
| 72 | 华仁药业 | 0.00% | 5.68% | 6.6分 |
| 74 | 昂利康 | -0.07% | 0.56% | 6.1分 |
| 76 | 奥翔药业 | -0.11% | 4.07% | 5.4分 |
| 78 | 南新制药 | -0.51% | 4.93% | 4.7分 |
| 80 | 海正药业 | -0.69% | 1.77% | 5.2分 |
| 82 | 振东制药 | -0.77% | 2.79% | 5.6分 |
| 84 | 千红制药 | -0.92% | 2.38% | 6.9分 |
| 86 | *ST景峰 | -0.98% | 11.21% | 5.0分 |
| 88 | 多瑞医药 | -1.08% | -0.56% | 5.7分 |
| 90 | 新天地 | -1.21% | 2.45% | 6.2分 |
| 92 | 哈三联 | -1.51% | 1.75% | 5.6分 |
| 94 | 华北制药 | -1.53% | 3.02% | 5.2分 |
| 96 | 民生健康 | -1.64% | 1.99% | 5.8分 |
| 98 | 福元医药 | -1.95% | -0.62% | 4.9分 |
| 100 | 普洛药业 | -2.08% | -1.08% | 6.8分 |
| 102 | 华纳药厂 | -2.29% | 0.47% | 5.2分 |
| 104 | 纳微科技 | -2.42% | 2.85% | 5.1分 |
| 106 | 健康元 | -2.61% | 0.26% | 5.1分 |
| 108 | 上海谊众 | -2.97% | -2.05% | 4.2分 |
| 110 | 海辰药业 | -3.47% | 0.68% | 4.8分 |
| 112 | 海翔药业 | -3.55% | 1.19% | 5.8分 |
| 114 | 华润双鹤 | -3.79% | -2.35% | 4.8分 |
| 116 | 亚虹医药 | -3.97% | 1.18% | 5.0分 |
| 118 | 神奇制药 | -4.50% | 2.20% | 5.4分 |
| 120 | 悦康药业 | -4.62% | 1.18% | 5.5分 |
| 122 | 拓新药业 | -4.70% | 0.86% | 4.9分 |
| 124 | 复旦张江 | -4.99% | 1.30% | 4.8分 |
| 126 | 花园生物 | -5.86% | 2.28% | 5.5分 |
| 128 | 联环药业 | -6.32% | 1.81% | 5.4分 |
| 130 | 赛托生物 | -7.13% | -1.04% | 5.1分 |
| 132 | 华特达因 | -7.28% | -1.48% | 5.3分 |
| 134 | 仙琚制药 | -7.33% | -1.66% | 5.2分 |
| 136 | 首药控股 | -7.69% | -1.10% | 4.3分 |
| 138 | 浙江医药 | -8.42% | 5.31% | 5.2分 |
| 140 | 新和成 | -9.15% | -1.38% | 5.6分 |
| 142 | 常山药业 | -9.97% | 2.86% | 5.1分 |
| 144 | 海南海药 | -10.23% | 2.66% | 5.6分 |
| 146 | 川宁生物 | -11.69% | 0.68% | 5.4分 |
| 148 | 科源制药 | -14.31% | -2.24% | 4.6分 |
| 150 | 富祥药业 | -22.52% | -15.70% | 4.0分 |
| 152 | - | - | -38.25% | 分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2024-09-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 18/225 ， 114/225。
[{"date":"2024-09-30","value":"11.89","vol":"4.45"},{"date":"2024-06-30","value":"7.92","vol":"3.44"},{"date":"2024-03-31","value":"4.01","vol":"2.32"},{"date":"2023-12-31","value":"14.33","vol":"-1.67"},{"date":"2023-09-30","value":"11.26","vol":"2.50"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
11.89 | 7.92 | 4.01 | 14.33 | 11.26 |
| 行业(%) | 4.45 | 3.44 | 2.32 | -1.67 | 2.50 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"32.55","vol":"50.26"},{"date":"2024-06-30","value":"32.70","vol":"50.64"},{"date":"2024-03-31","value":"32.03","vol":"50.50"},{"date":"2023-12-31","value":"32.40","vol":"51.43"},{"date":"2023-09-30","value":"31.86","vol":"51.50"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
32.55 | 32.70 | 32.03 | 32.40 | 31.86 |
| 行业(%) | 50.26 | 50.64 | 50.50 | 51.43 | 51.50 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 60/225 ， 62/225。
[{"date":"2024-09-30","value":"3.56","vol":"44.85"},{"date":"2024-06-30","value":"2.84","vol":"709.33"},{"date":"2024-03-31","value":"2.93","vol":"754.34"},{"date":"2023-12-31","value":"7.71","vol":"357.93"},{"date":"2023-09-30","value":"9.10","vol":"123.78"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
3.56 | 2.84 | 2.93 | 7.71 | 9.10 |
| 行业(%) | 44.85 | 709.33 | 754.34 | 357.93 | 123.78 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"17.05","vol":"-20.63"},{"date":"2024-06-30","value":"18.29","vol":"4.81"},{"date":"2024-03-31","value":"14.18","vol":"19.22"},{"date":"2023-12-31","value":"13.59","vol":"-47.97"},{"date":"2023-09-30","value":"10.48","vol":"13.66"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
17.05 | 18.29 | 14.18 | 13.59 | 10.48 |
| 行业(%) | -20.63 | 4.81 | 19.22 | -47.97 | 13.66 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 3/225 ， 11/225。
[{"date":"2024-09-30","value":"0.89","vol":"0.33"},{"date":"2024-06-30","value":"0.60","vol":"0.23"},{"date":"2024-03-31","value":"0.31","vol":"0.12"},{"date":"2023-12-31","value":"1.26","vol":"0.44"},{"date":"2023-09-30","value":"0.93","vol":"0.33"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.89 | 0.60 | 0.31 | 1.26 | 0.93 |
| 行业(次) | 0.33 | 0.23 | 0.12 | 0.44 | 0.33 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"4.62","vol":"2.18"},{"date":"2024-06-30","value":"3.26","vol":"1.51"},{"date":"2024-03-31","value":"1.66","vol":"0.75"},{"date":"2023-12-31","value":"6.25","vol":"2.81"},{"date":"2023-09-30","value":"4.41","vol":"2.05"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
4.62 | 3.26 | 1.66 | 6.25 | 4.41 |
| 行业(次) | 2.18 | 1.51 | 0.75 | 2.81 | 2.05 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2024-09-30","value":"2.20","vol":"-10.59"},{"date":"2024-06-30","value":"26.15","vol":"-256.17"},{"date":"2024-03-31","value":"-4.65","vol":"-4.62"},{"date":"2023-12-31","value":"16.42","vol":"-124.97"},{"date":"2023-09-30","value":"2.27","vol":"-16.91"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 2.20 | 26.15 | -4.65 | 16.42 | 2.27 |
| 行业 | -10.59 | -256.17 | -4.62 | -124.97 | -16.91 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"1.54","vol":"2.19"},{"date":"2024-03-31","value":"","vol":"0.00"},{"date":"2023-12-31","value":"1.96","vol":"2.33"},{"date":"2023-09-30","value":"","vol":"0.00"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.54 | - | 1.96 | - |
| 行业 | 0.00 | 2.19 | 0.00 | 2.33 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 34/225 ， 14/225。
[{"date":"2024-09-30","value":"1.48","vol":"3.60"},{"date":"2024-06-30","value":"1.54","vol":"3.53"},{"date":"2024-03-31","value":"1.76","vol":"3.76"},{"date":"2023-12-31","value":"1.71","vol":"3.67"},{"date":"2023-09-30","value":"1.68","vol":"3.99"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.48 | 1.54 | 1.76 | 1.71 | 1.68 |
| 行业 | 3.60 | 3.53 | 3.76 | 3.67 | 3.99 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"1.11","vol":"2.89"},{"date":"2024-06-30","value":"1.18","vol":"2.85"},{"date":"2024-03-31","value":"1.33","vol":"3.10"},{"date":"2023-12-31","value":"1.28","vol":"2.98"},{"date":"2023-09-30","value":"1.23","vol":"3.25"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.11 | 1.18 | 1.33 | 1.28 | 1.23 |
| 行业 | 2.89 | 2.85 | 3.10 | 2.98 | 3.25 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 41/225 ， 54/225。
[{"date":"2024-09-30","value":"39.80","vol":"33.18"},{"date":"2024-06-30","value":"38.39","vol":"33.32"},{"date":"2024-03-31","value":"34.76","vol":"33.07"},{"date":"2023-12-31","value":"35.59","vol":"33.58"},{"date":"2023-09-30","value":"38.40","vol":"32.43"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
39.80 | 38.39 | 34.76 | 35.59 | 38.40 |
| 行业(%) | 33.18 | 33.32 | 33.07 | 33.58 | 32.43 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"0.68","vol":"0.73"},{"date":"2024-06-30","value":"0.64","vol":"0.71"},{"date":"2024-03-31","value":"0.55","vol":"0.70"},{"date":"2023-12-31","value":"0.57","vol":"0.75"},{"date":"2023-09-30","value":"0.64","vol":"0.72"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.68 | 0.64 | 0.55 | 0.57 | 0.64 |
| 行业(%) | 0.73 | 0.71 | 0.70 | 0.75 | 0.72 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 华泰金融(HK) | 2024-11-29 | 买入 | 买入 |
| 国联证券 | 2024-11-21 | 买入 | |
| 华泰证券 | 2024-11-12 | 买入 | 买入 |
| 浙商证券 | 2024-11-12 | 买入 | |
| 华创证券 | 2024-11-10 | 增持 | |
| 长江证券 | 2024-11-10 | 买入 |
机构预测
机构预测该股2024年每股收益与前一年相同，长期投资价值一般。
[{"date":"2020","yellowRectValue":"28.20","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"23.02","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"24.99","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"28.39","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"33.47","blueLineValue":"1.91","type":"YC"}]